JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M501955200 on April 18, 2005

J. Biol. Chem., Vol. 280, Issue 27, 25802-25810, July 8, 2005
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
280/27/25802    most recent
M501955200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lotan, R.
Right arrow Articles by Larisch, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lotan, R.
Right arrow Articles by Larisch, S.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Regulation of the Proapoptotic ARTS Protein by Ubiquitin-mediated Degradation*

Rona Lotan{ddagger}§, Asaf Rotem{ddagger}§, Hedva Gonen¶, John P. M. Finberg||, Stav Kemeny{ddagger}, Hermann Steller**{ddagger}{ddagger}, Aaron Ciechanover¶, and Sarit Larisch{ddagger}§§

From the {ddagger}Apoptosis and Cancer Research Laboratory, Pathology Department, Rambam Medical Center, Bat-Galim, Haifa 31096, Israel,|| Pharmacology Unit, Rappaport Faculty of Medicine, Technion, P.O.B. 9649, Haifa 31096, Israel, Department of Biochemistry and the Rappaport Institute for Research in the Medical Sciences, The Bruce Rappaport Faculty of Medicine, Haifa 31096, Israel, and the **Howard Hughes Medical Institute, Strang Laboratory of Cancer Research, The Rockefeller University, New York, New York 10021

ARTS is a mitochondrial protein that promotes apoptosis induced by a variety of proapoptotic stimulators. ARTS induces apoptosis, at least in part, through binding to and antagonizing IAPs (inhibitors of apoptosis proteins). As a result of ARTS binding to IAPs, caspase inhibition is removed and apoptosis can be executed. Here we show that high cellular levels of ARTS protein sensitize cells toward apoptosis. Accordingly, in healthy cells ARTS levels are kept low through constant ubiquitin-mediated degradation. Upon proapoptotic stimuli, the ubiquitination process is inhibited, resulting in increased levels of ARTS. Increased ARTS in turn leads to a decrease of Bcl-2 and Bcl-xL protein levels, cytochrome c release from mitochondria and apoptosis.


Received for publication, February 22, 2005 , and in revised form, April 11, 2005.

* This work was supported in part by a Fogarty International Research Collaboration Award (FIRCA) from the National Institutes of Health (to H. S. and S. L.), Grant 486-02 from the Israel Science Foundation (to S. L.), and the Chutick Fund (to Technion, S. L., and J. P. M. F.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ These authors contributed equally to this work.

{ddagger}{ddagger} An Investigator with the Howard Hughes Medical Institute.

§§ To whom correspondence should be addressed: Apoptosis and Cancer Research Laboratory, Pathology Dept., Rambam Medical Center, Haifa 31096, Israel. Tel.: 972-4-8543464; Fax: 972-4-8542877; E-mail: s_larisch{at}rambam.health.gov.il.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
BloodHome page
F.-T. Liu, S. G. Agrawal, J. G. Gribben, H. Ye, M.-Q. Du, A. C. Newland, and L. Jia
Bortezomib blocks Bax degradation in malignant B cells during treatment with TRAIL
Blood, March 1, 2008; 111(5): 2797 - 2805.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. G. Agrawal, F.-T. Liu, C. Wiseman, S. Shirali, H. Liu, D. Lillington, M.-Q. Du, D. Syndercombe-Court, A. C. Newland, J. G. Gribben, et al.
Increased proteasomal degradation of Bax is a common feature of poor prognosis chronic lymphocytic leukemia
Blood, March 1, 2008; 111(5): 2790 - 2796.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
N. Y. Fu, S. K. Sukumaran, and V. C. Yu
Inhibition of ubiquitin-mediated degradation of MOAP-1 by apoptotic stimuli promotes Bax function in mitochondria
PNAS, June 12, 2007; 104(24): 10051 - 10056.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.